Lipella Pharmaceuticals Inc. (LIPO)

Lipella Pharmaceuticals Statistics

Total Valuation

LIPO has a market cap or net worth of $2.91 million. The enterprise value is $1.63 million.

Market Cap	2.91M
Enterprise Value	1.63M

Important Dates

The last earnings date was Thursday, November 14, 2024, after market close.

Earnings Date	Nov 14, 2024
Ex-Dividend Date	n/a

Share Statistics

LIPO has 1.21 million shares outstanding. The number of shares has increased by 41.54% in one year.

Current Share Class	1.21M
Shares Outstanding	1.21M
Shares Change (YoY)	+41.54%
Shares Change (QoQ)	+17.72%
Owned by Insiders (%)	29.37%
Owned by Institutions (%)	3.85%
Float	853,831

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4.77
Forward PS	n/a
PB Ratio	1.80
P/TBV Ratio	2.00
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	3.37
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.97, with a Debt / Equity ratio of 0.05.

Current Ratio	2.97
Quick Ratio	1.97
Debt / Equity	0.05
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -231.67% and return on invested capital (ROIC) is -139.38%.

Return on Equity (ROE)	-231.67%
Return on Assets (ROA)	-108.95%
Return on Capital (ROIC)	-139.38%
Revenue Per Employee	$69,076
Profits Per Employee	-$609,068
Employee Count	7
Asset Turnover	0.19
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -73.57% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-73.57%
50-Day Moving Average	3.23
200-Day Moving Average	4.79
Relative Strength Index (RSI)	38.00
Average Volume (20 Days)	127,961

Short Selling Information

The latest short interest is 18,191, so 1.50% of the outstanding shares have been sold short.

Short Interest	18,191
Short Previous Month	174,738
Short % of Shares Out	1.50%
Short % of Float	2.13%
Short Ratio (days to cover)	0.01

Income Statement

In the last 12 months, LIPO had revenue of $483,533 and -$4.26 million in losses. Loss per share was -$4.46.

Revenue	483,533
Gross Profit	-2.56M
Operating Income	-4.36M
Pretax Income	-4.74M
Net Income	-4.26M
EBITDA	-4.36M
EBIT	-4.36M
Loss Per Share	-$4.46

Balance Sheet

The company has $1.35 million in cash and $70,830 in debt, giving a net cash position of $1.28 million or $1.06 per share.

Cash & Cash Equivalents	1.35M
Total Debt	70,830
Net Cash	1.28M
Net Cash Per Share	$1.06
Equity (Book Value)	1.46M
Book Value Per Share	1.34
Working Capital	1.38M

Cash Flow

Operating Cash Flow	-3.69M
Capital Expenditures	n/a
Free Cash Flow	-3.69M
FCF Per Share	-$3.05

Margins

Gross Margin	n/a
Operating Margin	-901.46%
Pretax Margin	-881.73%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-727.84%

Dividends & Yields

LIPO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-41.54%
Shareholder Yield	-41.54%
Earnings Yield	-146.33%
FCF Yield	-126.58%

Analyst Forecast

The average price target for LIPO is $16.00, which is 563.90% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$16.00
Price Target Difference	563.90%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on November 8, 2024. It was a reverse split with a ratio of 0.125:1.

Last Split Date	Nov 8, 2024
Split Type	Reverse
Split Ratio	0.125:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1